Regions Financial Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$272M Sell
295,365
-43,992
-13% -$44.6M 1.76% 14
2025
Q4
$365M Sell
339,357
-4,229
-1% -$4.04M 2.33% 10
2025
Q3
$262M Sell
343,586
-4,286
-1% -$3.19M 1.71% 12
2025
Q2
$271M Sell
347,872
-8,842
-2% -$6.87M 1.87% 11
2025
Q1
$295M Sell
356,714
-18,178
-5% -$15.1M 2.2% 8
2024
Q4
$289M Buy
374,892
+6,460
+2% +$5.35M 2.13% 9
2024
Q3
$326M Buy
368,432
+2,238
+0.6% +$2.01M 2.35% 7
2024
Q2
$332M Sell
366,194
-9,579
-3% -$7.66M 2.52% 7
2024
Q1
$292M Sell
375,773
-9,717
-3% -$6.92M 2.22% 7
2023
Q4
$225M Sell
385,490
-26,251
-6% -$15.3M 1.85% 9
2023
Q3
$221M Sell
411,741
-3,988
-1% -$2.05M 1.99% 8
2023
Q2
$195M Sell
415,729
-11,006
-3% -$4.62M 1.68% 11
2023
Q1
$147M Sell
426,735
-30,281
-7% -$10.2M 1.32% 16
2022
Q4
$167M Sell
457,016
-10,100
-2% -$3.58M 1.54% 14
2022
Q3
$151M Sell
467,116
-9,434
-2% -$2.99M 1.52% 9
2022
Q2
$155M Sell
476,550
-42,087
-8% -$12.6M 1.47% 10
2022
Q1
$149M Sell
518,637
-3,002
-0.6% -$773K 1.2% 16
2021
Q4
$144M Sell
521,639
-9,301
-2% -$2.36M 1.12% 16
2021
Q3
$123M Sell
530,940
-41,659
-7% -$10.3M 1.06% 17
2021
Q2
$131M Sell
572,599
-11,137
-2% -$2.24M 1.14% 15
2021
Q1
$109M Sell
583,736
-12,001
-2% -$2.35M 0.99% 25
2020
Q4
$101M Sell
595,737
-13,839
-2% -$2.07M 0.97% 27
2020
Q3
$90.2M Sell
609,576
-29,071
-5% -$4.5M 0.98% 24
2020
Q2
$105M Sell
638,647
-20,041
-3% -$3.08M 1.22% 20
2020
Q1
$91.4M Sell
658,688
-32,726
-5% -$4.5M 1.22% 20
2019
Q4
$90.9M Buy
691,414
+11,108
+2% +$1.29M 0.95% 25
2019
Q3
$76.1M Buy
680,306
+13,811
+2% +$1.54M 0.84% 30
2019
Q2
$73.8M Sell
666,495
-12,324
-2% -$1.45M 0.83% 31
2019
Q1
$88.1M Sell
678,819
-74,999
-10% -$9.12M 1.01% 24
2018
Q4
$87.2M Sell
753,818
-60,851
-7% -$6.8M 1.09% 22
2018
Q3
$87.4M Sell
814,669
-31,166
-4% -$3.12M 0.94% 28
2018
Q2
$72.2M Sell
845,835
-1,364
-0.2% -$112K 0.81% 35
2018
Q1
$65.5M Sell
847,199
-381,290
-31% -$30.7M 0.74% 42
2017
Q4
$104M Buy
1,228,489
+24,471
+2% +$2.08M 1.12% 21
2017
Q3
$103M Buy
1,204,018
+3,169
+0.3% +$260K 1.17% 22
2017
Q2
$98.8M Sell
1,200,849
-278,845
-19% -$22.7M 1.16% 20
2017
Q1
$124M Buy
1,479,694
+267,327
+22% +$21.4M 1.47% 12
2016
Q4
$89.2M Buy
1,212,367
+705,148
+139% +$52.5M 1.09% 25
2016
Q3
$40.7M Sell
507,219
-37,079
-7% -$2.97M 0.52% 63
2016
Q2
$42.9M Sell
544,298
-76,019
-12% -$5.72M 0.56% 57
2016
Q1
$44.7M Buy
620,317
+16,634
+3% +$1.26M 0.59% 55
2015
Q4
$50.9M Buy
603,683
+9,119
+2% +$757K 0.68% 40
2015
Q3
$49.8M Buy
594,564
+8,612
+1% +$727K 0.71% 39
2015
Q2
$48.9M Buy
585,952
+3,186
+0.5% +$243K 0.65% 40
2015
Q1
$42.3M Buy
582,766
+10,376
+2% +$739K 0.54% 55
2014
Q4
$39.5M Sell
572,390
-2,156
-0.4% -$146K 0.51% 54
2014
Q3
$37.3M Buy
574,546
+29,205
+5% +$1.85M 0.46% 63
2014
Q2
$33.9M Buy
545,341
+110,016
+25% +$6.56M 0.42% 77
2014
Q1
$25.6M Buy
435,325
+312,343
+254% +$17.4M 0.33% 94
2013
Q4
$6.27M Sell
122,982
-2,408
-2% -$121K 0.08% 164
2013
Q3
$6.31M Sell
125,390
-3,910
-3% -$205K 0.08% 164
2013
Q2
$6.35M Buy
+129,300
New +$7.04M 0.09% 159

Other funds holding LLY

Regions Financial Corp's LLY Position: Q1 2026 in Review

Regions Financial Corp reduced its Eli Lilly (LLY) stake by 13% in Q1 2026, selling an estimated $44.6M and leaving 295,365 shares worth $272M. The position accounts for 1.76% of the portfolio, ranked #14.

Regions Financial Corp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $365M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Regions Financial Corp held 295,365 shares of Eli Lilly worth $272M as of Q1 2026.
  • Regions Financial Corp sold 43,992 Eli Lilly shares in Q1 2026, an estimated $44.6M.
  • Eli Lilly made up 1.76% of Regions Financial Corp's portfolio in Q1 2026, its #14 holding.
  • Regions Financial Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Regions Financial Corp's Eli Lilly position peaked at $365M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.